文献速递银屑病与炎症性皮肤病皮肤肿瘤

银屑病与癌症发生及死亡风险的系统综述与荟萃分析

Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Dermatol · 2019-01-01

该系统综述与荟萃分析纳入58项观察性研究,评估银屑病患者癌症发生与死亡风险。结果显示重度银屑病与总体癌症风险升高相关(RR 1.22,95%CI 1.08-1.39),多种部位特异性癌症风险亦升高;重度银屑病患者的总体癌症死亡风险更高(RR 1.22,95%CI 1.08-1.38)。调整吸烟、饮酒和肥胖后风险估计明显减弱。

要点

  • 重度银屑病患者总体癌症发生风险升高(RR 1.22,95%CI 1.08-1.39)。
  • 银屑病与多种部位特异性癌症风险升高相关,包括皮肤鳞状细胞癌等。
  • 重度银屑病患者总体癌症死亡风险升高(RR 1.22,95%CI 1.08-1.38)。

核心结论

  • 银屑病患者似乎存在癌症发生和癌症相关死亡风险增加,涉及多种部位特异性癌症。

研究设计与样本

  • 系统综述与荟萃分析,检索6个电子数据库至2017年11月15日,纳入58项队列和病例对照研究。

主要发现

  • 重度银屑病与总体癌症风险升高相关(RR 1.22,95%CI 1.08-1.39,9项研究)。
  • 所有严重程度的银屑病与总体癌症风险升高相关(RR 1.18,95%CI 1.06-1.31,7项研究)。
  • 部位特异性癌症风险升高包括结肠癌(RR 1.18,95%CI 1.03-1.35)、结直肠癌(RR 1.34,95%CI 1.06-1.70)、肾癌(RR 1.58,95%CI 1.11-2.24)、喉癌(RR 1.79,95%CI 1.06-3.01)、肝癌(RR 1.83,95%CI 1.28-2.61)、淋巴瘤(RR 1.40,95%CI 1.24-1.57)、非霍奇金淋巴瘤(RR 1.28,95%CI 1.15-1.43)、角质形成细胞癌(RR 1.71,95%CI 1.08-2.71)、食管癌(RR 2.05,95%CI 1.04-4.07)、口腔癌(RR 2.80,95%CI 1.99-3.93)和胰腺癌(RR 1.41,95%CI 1.16-1.73)。
  • 重度银屑病患者总体癌症死亡风险升高(RR 1.22,95%CI 1.08-1.38,4项研究)。
  • 重度银屑病患者肝癌死亡风险(RR 1.43,95%CI 1.09-1.88)、食管癌死亡风险(RR 2.53,95%CI 1.87-3.41)和胰腺癌死亡风险(RR 1.31,95%CI 1.02-1.69)升高。

临床怎么用

  • 对银屑病患者,尤其是重度患者,应关注癌症风险评估与筛查。
  • 临床管理中需考虑吸烟、饮酒和肥胖等生活方式因素对癌症风险的影响。

局限性

  • 纳入研究质量参差不齐,异质性通常很高,即使分层后亦如此。
  • 调整吸烟、饮酒和肥胖后风险估计明显减弱,提示残余混杂可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The risk of cancer developing in people with psoriasis has raised some concern, with little clarity regarding differentiation in risk according to psoriasis severity. OBJECTIVE: To conduct a systematic review and meta-analysis of observational studies on the risk of cancer incidence and mortality in people with psoriasis. DATA SOURCES: Six electronic databases (MEDLINE, Embase, MEDLINE in Process, Cochrane Central Register, Web of Science, and LILACS [Literatura Latino-Americana e do Caribe em Ciências da Saúde]) were searched from inception to November 15, 2017, for eligible studies. STUDY SELECTION: Cohort and case-control studies that provided estimates of the risk of cancer incidence or cancer mortality associated with psoriasis were included. DATA EXTRACTION AND SYNTHESIS: Data were extracted relating to study design, study population, and risk estimates. Study-specific estimates of the relative risk (RR) were combined using a random-effects model. Heterogeneity was quantified using the I2 statistic. Data were analyzed from April 9, 2018, through February 22, 2019. MAIN OUTCOMES AND MEASURES: Pooled RR estimates for cancer incidence and cancer mortality for psoriasis cohorts compared with people without psoriasis. RESULTS: A total of 58 unique studies were included, with quality varying for the incidence and the mortality studies. Severe psoriasis (RR, 1.22; 95% CI, 1.08-1.39 [9 studies]) and all severities of psoriasis (RR, 1.18; 95% CI, 1.06-1.31 [7 studies]) were associated with an increased risk of cancer (overall), and associations were found for a range of site-specific cancers, including colon (RR, 1.18 [95% CI, 1.03-1.35]), colorectal (RR, 1.34 [95% CI, 1.06-1.70]), kidney (RR, 1.58 [95% CI, 1.11-2.24]), laryngeal (RR, 1.79 [95% CI, 1.06-3.01]), liver (RR, 1.83 [95% CI, 1.28-2.61]), lymphoma (RR, 1.40 [95% CI, 1.24-1.57]), non-Hodgkin lymphoma (RR, 1.28 [95% CI, 1.15-1.43]), keratinocyte cancers (RR, 1.71 [95% CI, 1.08-2.71]), esophageal (RR, 2.05 [95% CI, 1.04-4.07]), oral cavity (RR, 2.80 [95% CI, 1.99-3.93]), and pancreatic (RR, 1.41 [95% CI, 1.16-1.73]). Overall cancer mortality risk was higher in patients with severe psoriasis (RR, 1.22; 95% CI, 1.08-1.38 [4 studies]). Specifically, liver (RR, 1.43 [95% CI, 1.09-1.88]), esophageal (RR, 2.53 [95% CI, 1.87-3.41]), and pancreatic (RR, 1.31 [95% CI, 1.02-1.69]) cancer mortality were found to be elevated in those with severe psoriasis. The heterogeneity of estimates was often very high despite stratification. Marked attenuation of risk was found in those studies that adjusted estimates for smoking, alcohol consumption, and obesity. CONCLUSIONS AND RELEVANCE: In this study, people with psoriasis appeared to have an increased risk of cancer incidence and cancer-related mortality involving a range of site-specific cancers. Future research examining specific lifestyle factors, treatments, and the inflammatory processes that contribute to psoriasis may help provide additional information on the underlying mechanisms for the apparent increased cancer risk.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Trafford AM, Parisi R, Kontopantelis E, et al. Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019. PMID: 31617868. doi:10.1001/jamadermatol.2019.3056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。